姓名:蔡郁棻  Yu-Fen Tsai    科別:血液腫瘤科    論文篇數: 7


AuthorTitleSourceYear
Yu-Fen Tsai, Yi-Chang Liu, Ching-I Yang, et alPoor Prognosis of Diffuse Large B-Cell Lymphoma with Hepatitis C Infection.J Pers Med. 2021 Aug 27;11(9):844. doi: 10.3390/jpm11090844.2021
Yu-Fen Tsai, Yen-Yun Wang, Wan-Chi Tsai, Chang-Wei Su, Ching-Wei Hsu, Shyng-Shiou F Yuan.Decreased Circulating Melatonin with Loss of Age-Related Biphasic Change in Patients with Oral Squamous Cell Carcinoma.J Pers Med. 2021 Dec 13;11(12):1357. doi: 10.3390/jpm11121357.2021
Yu-Fen Tsai, Chin-Mu Hsu, Hui-Hua Hsiao.Management of Hepatitis B Virus Reactivation in Malignant Lymphoma Prior to Immunosuppressive Treatment.J Pers Med. 2021 Apr 2;11(4):267. doi: 10.3390/jpm11040267.2021
Chien-Ting Liu, Meng-Che Hsieh, Yu-Li Su, Chaio-Ming Hung, Sung-Nan Pei, Chun-Kai Liao, Yu-Fen Tsai, Hsiu-Yun Liao, Wei-Ching Liu, Chong-Chi Chiu, Shih-Chung Wu, Shih-Ho Wang, Ching-Ting Wei, Kun-Ming Rau.Metronomic vinorelbine is an excellent and safe treatment for advanced breast cancer: a retrospective, observational study.J Cancer. 2021 Jul 3;12(17):5355-5364. doi: 10.7150/jca.60682.2021
Sung-Nan Pei, Chun-Kai Liao, Yaw-Sen Chen, Cheng-Hao Tseng, Chao-Ming Hung, Chong-Chi Chiu6, Meng-Che Hsieh, Yu-Fen Tsai, Hsiu-Yun Liao, Wei-Ching Liu, Kun-Ming Rau.A Novel Combination of Bevacizumab with Chemotherapy Improves Therapeutic Effects for Advanced Biliary Tract Cancer: A Retrospective, Observational Study.Cancers (Basel). 2021 Jul 29;13(15):3831.2021
Kun-Ming Rau, Chao-Sung Chang, Sung-Nan Pei, Meng-Che Hsieh, Yu-Fen Tsai, Chong-Chi Chiu.Comment on: Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis.Br J Surg. 2021 Mar 12:znab055. doi: 10.1093/bjs/znab055. Epub ahead of print.2021
Meng-Che Hsieh, Shih-Ho Wang, Ching-Ting Wei, Chung-Yen Chen, Yen-Yang Chen, Sung-Nan Pei, Yu-Fen Tsai, Kun-Ming Rau.S1 versus Doublet Regimens as Adjuvant Chemotherapy in Patients with Advanced Gastric Cancer after Radical Surgery with D2 Dissection-A Propensity Score Matching Analysis.Cancers (Basel). 2020 Aug 23;12(9):E2384. doi: 10.3390/cancers12092384. PMID: 32842507.2020